Literature DB >> 8066565

Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.

F Rodríguez de Castro1, T Molero, O Acosta, G Julià-Serdà, J Caminero, P Cabrera, T Carrillo.   

Abstract

BACKGROUND: Aneuploidy appears to be a highly specific marker for cancer, and measurement of cellular DNA content by flow cytometry is rapid and reliable. This study was undertaken to determine if the addition of DNA analysis improved the sensitivity of cytological diagnosis of malignancy in pleural fluid.
METHODS: Pleural effusions from 92 patients were studied by cytological examination and flow cytometry.
RESULTS: In 41 patients the final diagnosis was malignancy, there were 40 cases of benign effusions including 22 with pleural tuberculosis, and in the remaining 11 patients with biopsy proven cancer the presence of malignant cells was not found by cytological and histological means in the pleural fluid. Aneuploidy and cytological malignancy were found in 14 samples. There were seven cases with abnormal flow cytometry and negative cytological results. In 12 patients the cytological test results were positive but DNA analysis was normal. Thirty six samples of fluid were both diploid and cytologically negative. Of the 22 tuberculous effusions seven contained aneuploid cells. The sensitivity of DNA and cytological analysis was 51.2% and 63.4%, respectively. The specificity of DNA analysis was 74.5%.
CONCLUSIONS: DNA analysis of cells in malignant pleural effusions is both less sensitive and specific than the cytological diagnosis. Flow cytometric analysis is not recommended for routine use in the diagnosis of pleural effusions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8066565      PMCID: PMC475059          DOI: 10.1136/thx.49.7.692

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  THE COMPARATIVE DIAGNOSTIC ACCURACY, EFFICIENCY AND SPECIFICITY OF CYTOLOGIC TECHNICS USED IN THE DIAGNOSIS OF MALIGNANT NEOPLASM IN SEROUS EFFUSIONS OF THE PLEURAL AND PERICARDIAL CAVITIES.

Authors:  H GRUNZE
Journal:  Acta Cytol       Date:  1964 Mar-Apr       Impact factor: 2.319

Review 2.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

3.  Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions.

Authors:  D W Hedley; J Philips; C A Rugg; I W Taylor
Journal:  Eur J Cancer Clin Oncol       Date:  1984-06

4.  Metastatic carcinoma of the pleura.

Authors:  P C Meyer
Journal:  Thorax       Date:  1966-09       Impact factor: 9.139

5.  Comparison of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids.

Authors:  R L Katz; T S Johnson; K D Williamson
Journal:  Anal Quant Cytol Histol       Date:  1985-09       Impact factor: 0.302

6.  Analysis of pleural effusions using automated flow cytometry.

Authors:  K M Unger; M Raber; C W Bedrossian; D A Stein; B Barlogie
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

7.  DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.

Authors:  D A Evans; J T Thornthwaite; A B Ng; E V Sugarbaker
Journal:  Anal Quant Cytol       Date:  1983-03

8.  Flow cytometric analysis and cytopathology of body cavity fluids.

Authors:  K J Stonesifer; J H Xiang; E J Wilkinson; N A Benson; R C Braylan
Journal:  Acta Cytol       Date:  1987 Mar-Apr       Impact factor: 2.319

9.  DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content.

Authors:  M M Pinto
Journal:  Anal Quant Cytol Histol       Date:  1992-06       Impact factor: 0.302

10.  Flow cytometry and Feulgen cytophotometry in evaluation of effusions.

Authors:  J Schneller; E Eppich; E Greenebaum; F Elequin; A Sherman; R Wersto; L G Koss
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

View more
  2 in total

1.  BMVC test, an improved fluorescence assay for detection of malignant pleural effusions.

Authors:  I-Ting Lin; Yu-Lin Tsai; Chi-Chih Kang; Wei-Chun Huang; Chiung-Lin Wang; Mei-Ying Lin; Pei-Jen Lou; Jin-Yuan Shih; Hao-Chien Wang; Huey-Dong Wu; Tzu-Hsiu Tsai; I-Shiow Jan; Ta-Chau Chang
Journal:  Cancer Med       Date:  2014-01-10       Impact factor: 4.452

2.  Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

Authors:  M Fiegl; C Tueni; T Schenk; R Jakesz; M Gnant; A Reiner; M Rudas; H Pirc-Danoewinata; C Marosi; H Huber
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.